LivingGLP1
Study S000266

Efficacy, Safety and Treatment Satisfaction of Once Weekly Tirzepatide in Obese Type 2 Diabetic Patients at a Tertiary Care Centre

Registration

Registration
NCT07728318
Study type
INTERVENTIONAL
Allocation
NON_RANDOMIZED
Masking
NONE
Status
NOT_YET_RECRUITING
Enrollment
52
Start
2026-08-12
Primary completion
2027-01-12
Lead sponsor
Akhtar Saeed Medical and Dental College
Conditions
Type 2 Diabetes Mellitus (T2DM), Obesity, Overweight
Interventions
OTHER:Tirzepatide + Standard Therapy (Intervention Group); OTHER:Standard Oral Antidiabetic Drugs (OADs)
Results posted
FALSE
Individual participant data sharing
UNDECIDED

Registered primary outcomes

  • Change in Glycemic Control (HbA1c) [Baseline, 3 months, and 6 months]
  • Change in Body Weight [Baseline and monthly up to 6 months]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.